Publications

• Tandem mass spectrometry and newborn screening: Pilot data and review
  Filiano, J. J., Bellimer, S. G., & Kunz, P. L. (2002). Tandem mass spectrometry and newborn screening: Pilot data and review. PEDIATRIC NEUROLOGY, 26(3), 201–204.
• Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus
  Vij, R., Triadafilopoulos, G., Owens, D. K., Kunz, P., & Sanders, G. D. (2004). Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. GASTROINTESTINAL ENDOSCOPY, 60(5), 739–756.
• Escherichia coli O157 : H7 infection in nursing homes: Review of literature and report of recent outbreak
  Reiss, G., Kunz, P., Koin, D., & Keeffe, E. B. (2006). Escherichia coli O157 : H7 infection in nursing homes: Review of literature and report of recent outbreak. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 54(4), 680–684.
• Pathological response after chemoradiation for T3 rectal cancer. Chennupati, S. K., Kamaya, A., Fisher, G. A., Ford, J. M., Kunz, P., Itakura, H., … Chang, D. T. (2010). Pathological response after chemoradiation for T3 rectal cancer. Colorectal Disease , 12(7 Online), e24–30.
  
• Multimodality treatment with intensity modulated radiation therapy for esophageal cancer La, T. H., Minn, A. Y., Su, Z., Fisher, G. A., Ford, J. M., Kunz, P., … Chang, D. T. (2010). Multimodality treatment with intensity modulated radiation therapy for esophageal cancer. DISEASES OF THE ESOPHAGUS, 23(4), 300–308.
  
• Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis Chang, S. T., Zahn, J. M., Horecka, J., Kunz, P. L., Ford, J. M., Fisher, G. A., … Koong, A. C. (2009). Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis. JOURNAL OF TRANSLATIONAL MEDICINE, 7.
  
• 
  
• Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., … Chang, D. T. (2010). Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer. CANCER, 116(16), 3943–3952.
  
• Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., Kunz, P., … Pai, R. K. (2010). Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma. CANCER, 116(22), 5179–5187.
  
• Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Hara, W., Hsu, A., Kunz, P. A., Ford, J., Fisher, G. A., … Chang, D. T. (2011). Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. CANCER, 117(15), 3342–3351.
  
• F-18-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases Zissen, M. H., Kunz, P., Subbarayan, M., Chin, F. T., Conti, P. S., Fisher, G. A., & Quon, A. (2011). F-18-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. NUCLEAR MEDICINE COMMUNICATIONS, 32(5), 343–347.
  
• SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER Schellenberg, D., Kim, J., Ciristman-Skieller, C., Chun, C. L., Columbo, L. A., Ford, J. M., … Koong, A. C. (2011). SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(1), 181–188.
  
• HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population: Clinicopathologic Analysis With Proposed Approach to HER2 Assessment Kunz, P. L., Mojtahed, A., Fisher, G. A., Ford, J. M., Chang, D. T., Balise, R. R., … Pai, R. K. (2012). HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population: Clinicopathologic Analysis With Proposed Approach to HER2 Assessment. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(1), 13–24.
  
• Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection Norton, J. A., Harris, E. J., Chen, Y., Visser, B. C., Poultsides, G. A., Kunz, P. C., … Jensen, R. T. (2011). Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection. ARCHIVES OF SURGERY, 146(6), 724–732.
  
• Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. Kunz, P. L., & Fisher, G. A. (2010). Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. Clinical and Experimental Gastroenterology, 3, 79–86.
  
• Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., Ford, J. M., … Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E595–E601.
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• Neoadjuvant Imatinib for Borderline Resectable GIST Koontz, M. Z., Visser, B. M., & Kunz, P. L. (2012). Neoadjuvant Imatinib for Borderline Resectable GIST. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(12), 1477–1482.
  
• Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis Subramaniam, S., Zell, J. A., & Kunz, P. L. (2013). Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(1), 5–9.
  
• 
  
• Molecular analysis and prenatal diagnosis of human fumarase deficiency Coughlin, E. M., Christensen, E., Kunz, P. L., Krishnamoorthy, K. S., Walker, V., Dennis, N. R., … Shih, V. E. (1998). Molecular analysis and prenatal diagnosis of human fumarase deficiency. MOLECULAR GENETICS AND METABOLISM, 63(4), 254–262.
  
• 
  
• Pathological response after chemoradiation for T3 rectal cancer Chennupati, S. K., Kamaya, A., Fisher, G. A., Ford, J. M., Kunz, P., Itakura, H., … Chang, D. T. (2010). Pathological response after chemoradiation for T3 rectal cancer. COLORECTAL DISEASE, 12(7), E24–E30.
  
• Neuroendocrine Tumors Clinical Practice Guidelines in Oncology Kulke, M. H., Benson, A. B., Bergsland, E., Berlin, J. D., Blaszkowsky, L. S., Choti, M. A., … Dwyer, M. A. (2012). Neuroendocrine Tumors Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(6), 724–764.
  
• 
  
• 
  
• Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma Shultz, D. B., Chan, C., Shaffer, J. L., Kunz, P. L., Koong, A. C., & Chang, D. T. (2014). Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma. PANCREAS, 43(5), 777–783.
  
• A renaissance in therapeutic options for pancreatic neuroendocrine tumors. Kunz, P. L. (2012). A renaissance in therapeutic options for pancreatic neuroendocrine tumors. American Society of Clinical Oncology Educational Book / ASCO. American Society of Clinical Oncology. Meeting, 271–274.
  
• 
  
• False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Paudel, N., Kunz, P. L., Poultsides, G. A., Koong, A. C., & Chang, D. T. (2014). False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Practical Radiation Oncology, 4(6), 368–371.
  
• Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors. Cives, M., Kunz, P. L., Morse, B., Coppola, D., Schell, M. J., Campos, T., … Strosberg, J. R. (2015). Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors. Endocrine-Related Cancer, 22(1), 1–9.
  
• Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors Narayanan, S., & Kunz, P. L. (2015). Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(1), 109–117.
  
• Neuroendocrine Tumors, Version 1.2015 Kulke, M. H., Shah, M. H., Benson, A. B., Bergsland, E., Berlin, J. D., Blaszkowsky, L. S., … Freedman-Cass, D. (2015). Neuroendocrine Tumors, Version 1.2015. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(1), 78–108.
  
• 
  
• Carcinoid and Neuroendocrine Tumors: Building on Success Kunz, P. L. (2015). Carcinoid and Neuroendocrine Tumors: Building on Success. JOURNAL OF CLINICAL ONCOLOGY, 33(16), 1855-?
  
• Role of somatostatin analogues in the treatment of neuroendocrine tumors. Narayanan, S., & Kunz, P. L. (2015). Role of somatostatin analogues in the treatment of neuroendocrine tumors. Journal of the National Comprehensive Cancer Network , 13(1), 109–117.
  
• Carcinoid and neuroendocrine tumors: building on success. Kunz, P. L. (2015). Carcinoid and neuroendocrine tumors: building on success. Journal of Clinical Oncology , 33(16), 1855–1863.
  
• Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. Narayanan, S., & Kunz, P. L. (2016). Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. Hematology/Oncology Clinics of North America, 30(1), 163–177.
  
• DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications Liu, I. H., Ford, J. M., & Kunz, P. L. (2016). DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications. CANCER TREATMENT REVIEWS, 44, 1–9.
  
• Gastroenteropancreatic neuroendocrine tumors: diagnosis and classification. Kunz, P. L. (2015). Gastroenteropancreatic neuroendocrine tumors: diagnosis and classification. Clinical Advances in Hematology & Oncology : H&O, 13(5), 4–6.
  
• DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications. Liu, I. H., Ford, J. M., & Kunz, P. L. (2016). DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications. Cancer Treatment Reviews, 44, 1–9.
  
• 
  
• A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis Margonis, G. A., Samaha, M., Kim, Y., Postlewait, L. M. L., Kunz, P., Maithel, S., … Pawlik, T. M. (2016). A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. JOURNAL OF GASTROINTESTINAL SURGERY, 20(6), 1098–1105.
  
• Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials. Kunz, P. L., Balise, R. R., Fehrenbacher, L., Pan, M., Venook, A. P., Fisher, G. A., … Bergsland, E. K. (2016). Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials. Pancreas, 45(10), 1394–1400.